Pharmacokinetics of SNR15 and Urinary electrolyte excretion in Healthy Volunteers: a randomized, double-blind, placebo-controlled crossover study

INTERVENTION: placebo (single ingestion) ‐ washout period ‐ SNR15 A (single ingestion) ‐ washout period ‐ SNR15 B (single ingestion) SNR15 A (single ingestion) ‐ washout period ‐ SNR15 B (single ingestion) ‐ washout period ‐ placebo (single ingestion) SNR15 B (single ingestion) ‐ washout period ‐ placebo (single ingestion) ‐ washout period ‐ SNR15 A (single ingestion) CONDITION: Healthy Volunteer PRIMARY OUTCOME: Plasma concentration of SNR15 metabolite SECONDARY OUTCOME: Plasma concentration of SNR15; Urinary electrolyte excretion INCLUSION CRITERIA: 1)Subjects who can make self‐judgment and are voluntarily giving written informed consent. 2)Healthy males aged between 30 and 64. Healthy post‐menopausal females aged between 50 and 64 with no menstruation in the past 12 months. 3)Subjects who routinely do not take medicine, supplements, FOSHU, and/or health food which affect to the result of the study.